NEW YORK, Sept. 13, 2016 -- The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the Eastern District of New York on behalf of investors who purchased The Hain Celestial Group, Inc. (NASDAQ:HAIN) securities between November 5, 2015 and August 15, 2016.
Click here to learn about the case: http://www.wongesq.com/pslra/the-hain-celestial-group-inc. There is no cost or obligation to you.
According to the complaint, throughout the Class Period, Defendants made false and misleading statements and/or failed to disclose material adverse facts, including that: (1) Hain did not have sufficient controls over financial reporting; and (2) Hain failed to properly account for its revenue in connection with certain US distributors.
On August 15, 2016, Hain announced that it would delay the release of its fourth quarter and fiscal year 2016 financial results because the Company was evaluating whether the revenue associated with concessions granted to certain distributors in the U.S. was accounted for in the correct period. Hain also stated that it was evaluating its internal control over financial reporting.
If you suffered a loss in Hain you have until October 17, 2016 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff. To obtain additional information, contact Vincent Wong, Esq. either via email [email protected], by telephone at 212.425.1140, or visit http://www.wongesq.com/pslra/the-hain-celestial-group-inc.
Vincent Wong, Esq. is an experienced attorney that has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT: Vincent Wong, Esq. 39 East Broadway Suite 304 New York, NY 10002 Tel. 212.425.1140 Fax. 866.699.3880 E-Mail: [email protected]


Tesla Q1 2026 Deliveries Miss Estimates as AI Strategy Takes Center Stage
Trump Administration Plans 100% Tariffs on Pharmaceutical Imports
KPMG UK Cuts 440 Audit Jobs Amid Low Attrition and Cooling Professional Services Demand
SpaceX Eyes Historic IPO at $1.75 Trillion Valuation
Luxury Car Sales in the Middle East Take a Hit Amid Iran War
MATCH Act Targets ASML and Chinese Chipmakers in New U.S. Export Crackdown
Private Credit Under Pressure: Is a Slow-Motion Crisis Unfolding?
Annie Altman Amends Sexual Abuse Lawsuit Against OpenAI CEO Sam Altman
Ukrainian Drones and the #MadeByHousewives Movement: Kyiv Fires Back at Rheinmetall CEO
OpenAI Executive Shake-Up Ahead of Anticipated 2026 IPO
Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal
Cathay Pacific Holds Firm on Flight Capacity Amid Middle East Conflict and Rising Fuel Costs
Star Entertainment Secures $390M Refinancing Deal to Stabilize Operations
UAE's Largest Natural Gas Facility Suspended After Attack-Triggered Fire
RBC Capital: European Medtech Firms Show Minimal Middle East and Energy Risk Exposure
Apple Turns 50: From Garage Startup to AI Crossroads
Russell 1000 Companies Hit $2.2T Cash Record While Aggressively Reinvesting in Growth 



